Industry Events Calendar

Free Attendance for Drug Developers, Researchers, and Academics!

The 5th edition PREDiCT: 3D Oncology & Tissue Models Summit will return this September, with defined tracks and a fresh speaker line-up, bringing together preclinical scientists to discuss adoption, and commercialization of 3D models as an integral part of drug development study.

This completely online meeting will feature over 30+ senior Preclinical Scientists from oncology to cardiovascular to musculoskeletal and CNS backgrounds, to share their latest data and lessons learned from clinically translatable 3D models to disease modeling of mechanisms, to attempting complex multi-cellular/organ systems to boost our understanding of functionality, and physiological relevancy.

Embark on the 3D trailblazing community to boost your confidence in 3D models and accelerate bench to bedside drug development to provide a truly safe, and effective treatment for patients!

Register now

The Patient Experience Symposium is a one-of-a-kind conference that brings together leading stakeholders from across healthcare to improve and enhance patient experience. The most influential thought leaders, healthcare executives, clinical trial operators, and clinicians come here to exchange game-changing ideas and actionable strategies to enhance patient experience in their healthcare ecosystems. Attendees learn best practices and find answers to difficult patient experience issues, and leave with the power to build an unforgettable patient experience. Together, changing the face of patient experience.

Register now

The Migraine Symposium is a one-day educational event that expands attendees’ understanding of migraine with the help of presentations by more than 35 experts and advocates from around the country. The symposium is divided into two tracks, one tailored to medical professionals with CME credits available, and the other to patients and the general public, however, both programs are open to all attendees.

Professional symposium topics:

• Pediatric migraine
• Migraine, head injury, and vestibular migraine
• The link between migraine and mental health
• The interplay of migraine and GI health

The Warren Alpert Medical School of Brown University designates this live activity for a maximum of 8.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Register now

The only industry-led meeting dedicated to bringing together computational biologists, structural biologists, protein engineers,  and bioinformaticians.

Built with insights from the likes of AbbVie, Sanofi, Amgen, and Takeda; CDD for Biologics has been specifically designed to help biopharma companies define strategies to further adapt computational tools, mitigate data availability issues, and address computational-experimental challenges to add immediate value to their biologics pipelines.

This dedicated platform will enable you to address key challenges such as those of widespread data sharing, the experimental constraints of generating enough data, and the importance of overcoming data silo-ing with organizations, as well as exploring new opportunities including a novel, AI-derived approach, an automated high-throughput engineering platform, successfully deploying ML algorithms and more.

Register now

For the first time ever, CHI is excited to bring to you its Immunogenicity & Bioassay Summit in a virtual setting. Join CHI from the comfort of your own home or office! Now in its 12th year, the Immunogenicity & Bioassay Summit will examine the challenges currently facing the industry. Hear from industry leaders, academic and the regulatory authorities who will share NEW case studies, NEW perspectives, and NEW approaches. This year CHI present 3 Conference Programs, a Symposium, and 5 Short Courses. Through their virtual platform, you have the option to move between presentations taking place at the same time. Plus, delegates can enable a live chat feature, view a virtual exhibit & poster hall, attend happy hours, breakout discussions, and more. This virtual event is available “Live” & On-Demand and will take place on Eastern Daylight time.

Register now

Since its debut in 2002, the Bio-IT World Conference & Expo has been the world’s premier event showcasing technologies and analytic approaches that solve problems, accelerate science, and drive the future of precision medicine. Bio-IT World unites an ecosystem of over 3,000 leading life sciences, pharmaceutical, clinical, healthcare, informatics and technology experts in the field of biomedical research, drug discovery & development, and healthcare from around the world. With this united community, Bio-IT World is the place to explore the future of precision medicine and the technologies that are powering it.

Register now

Speak with STAT co-founder and executive editor Rick Berke, and Pharmalot columnist and senior writer Ed Silverman, about the pharma industry in 2020 and beyond.

Sponsored by:

Register now

Over the past 8 years, CHI’s Immuno-Oncology Summit has become the leading annual meeting focusing on the latest applied research, providing comprehensive and in-depth coverage across all modalities and stages in the pipeline. Every year, we assemble an international mix of thought leaders and decision makers from industry and academia to bring you the latest developments in immuno-oncology, while providing access to a comprehensive 3-day program and extensive networking opportunities that CHI’s IO Summit provides.

Register now

Advancing Continuous Bioprocessing to Enhance Productivity, Rapid Scale-Up Capabilities & Product Quality

Register now

Mike Edelhart, Managing Partner at Social Starts and Joyance Partners, will moderate this engaging panel to discuss new healthcare investment trends.

Sara Demy, CEO of Demy-Colton, hosts interactive virtual salons featuring industry leaders and distinguished guests exploring today’s most consequential and disruptive topics in healthcare.

Register now

For decades, Robert Califf, M.D., MACC, head of clinical policy and strategy for Verily and Google Health; adjunct professor, Duke University and Stanford University, has been an evangelist for randomized trials. Now, there’s new room for innovation. We’ll discuss how new technologies could change medical research without sacrificing rigor.

Register now

In today’s complex health care environment, change is constant.

Providers are challenged to deliver high-quality, high-value care that not only is safe and free from medical errors but also improves patient outcomes.

At the same time, new technology continues to transform the way health care is delivered on almost a weekly basis, making it difficult to contain costs, improve clinical efficiency, and achieve high impact leadership.

To this end Harvard Medical School (HMS) offers Safety, Quality, Informatics and Leadership (SQIL). This comprehensive program delivers the tools you need to become a global leader in health care quality and safety delivery.

SQIL is a one-year certificate program consisting of three in-person, 4-day workshops; dynamic live webinars and pre-recorded lectures; and team-based peer collaboration. This highly interactive program provides participants with direct access to the world’s leading authorities in safety, quality, clinical informatics, and health leadership.

Register now

During this course, attendees will learn about the mental health consequences of COVID-19 globally and practical strategies for promoting wellbeing. Acknowledging the wide spread emotional toll of the COVID-19 pandemic, a diverse array of experts will provide insight on how to bridge science and practice across different settings. Attendees will also have the opportunity to learn from individuals on the frontlines of treating mental health during the current pandemic.

Register now

Hear what the pandemic means for vaccine development, and what we can expect for the next few months, from STAT senior writer Helen Branswell.

Sponsored by:

Register now

Several clinical trials of B and plasma cell directed therapies are demonstrating positive results across a broad range of non-oncological, immune mediated diseases including systemic lupus erythematosus, rheumatoid arthritis, type 1 diabetes, multiple sclerosis, and Sjogren’s syndrome. However, the vast potential of developing next generation B cell directed therapies remains challenging with limited fundamental knowledge on the role of B and plasma cell subtypes in health, autoimmunity and the wider immune system.

This virtual summit arrives as the first ever cross-disciplinary meeting for large pharma, biotech, and academia. This forum is dedicated to harnessing the full therapeutic opportunity of numerous candidates directed against various B and plasma cell targets (incl. CD20, PI3K, BTK & more). Come armed with questions, ideas and experiences and together, take steps to develop the next generation of B cell directed therapies to improve immune mediated disease management, define effective combination treatment regimens, and transform patient outcomes.

Register now

Art Pappas, managing partner at Pappas Capital, will moderate a fireside chat with Amy Abernethy, Principal Deputy Commissioner of Food and Drug Administration.

Register now

The Microbiome Movement — Drug Development Summit continues to be the industry-leading forum to help forward thinking researchers from the pharmaceutical, biotech, and academic community pursue the causal role of the human microbiome in disease, to create a new generation of targeted treatments that demonstrate consistent clinical outcomes and predictable MoAs.

If you are, or would like to be, a player in the microbiome arena, this is the conference you should attend to not only hear the latest pre-clinical and clinical development from organizations developing microbiome-based therapeutics, biomarkers and diagnostics, but also to make long-lasting connections that will accelerate your microbiome developments forward, and help translate this promising science into a reality for patients.

Register now

Built in close consultation with IT QA/Compliance, IT Infrastructure and InfoSec professionals across the pharmaceutical industry, the first digital GxP Cloud Compliance Summit arrives to help the community develop a practical roadmap for migrating GxP-regulated applications to the cloud, with specific regulatory, data security, and implementation guidance.

As more life science organizations look to the cloud for lower infrastructure costs and greater operational efficiencies, join your peers to better equip yourself with the tools and strategies required to overcome the barriers of cloud adoption for regulated workloads, whilst maintaining enterprise compliance.

The GxP Cloud Compliance Summit is FREE to attend for all pharma and biotech.

Register now

In this Harvard Medical School webinar, Prem Ramaswami, Head of Product at Sidewalk Labs, an Alphabet company focused on increasing the sustainability and affordability of cities discusses when in the early days of COVID, he worked closely with Boston Children’s Hospital and Harvard Health Map to bring together a group of tech company volunteers to launch CovidNearYou.org, a crowd-sourced surveillance app. Previously, Prem led Google Search’s efforts around Social Impact including Health, Civics, Education, Crisis Response, and Social Good. While he was at Google, Prem helped develop and attended the first cohort of HMS’s Executive Education program for Google.

Register now

STAT national technology correspondent Casey Ross will be joined by Anne Heatherington, senior vice president and head of the Data Sciences Institute at Takeda, and Steven Kern, deputy director of quantitative sciences at the Bill & Melinda Gates Foundation, for a conversation about real world evidence.

Sponsored by:

Register now

Bringing together leading discovery scientists, developers, CMC experts, regulatory specialists, and technology providers, OPT Congress provides a unique opportunity to discuss advances in next-generation oligonucleotide therapies throughout the drug development process. Attend in 2020 to optimize your drug design, delivery and performance, accelerate time to market, and achieve commercial success. Based on the resounding success of last year’s inaugural 2-day program dedicated to oligonucleotide CMC & regulatory strategies Cambridge Healthtech Institute will once again be adding this content to complement their established oligonucleotide discovery and delivery conference.

Register now

The AI Applications in Biopharma Summit is the ONLY event founded on a proven interactive experience where our industry’s science minds, AI technology experts, technologists, and strategy leaders share detailed use cases and have open dialogue to collaboratively build out the adoption of AI technology to improve patients’ lives.

Register now

STAT’s San Francisco health tech correspondent, Erin Brodwin, will lead a discussion with Roy Schoenberg, M.D., MPH, Amwell’s president & co- CEO. 

Sponsored by:

Register now

Beth Rogozinski, CEO, Signal 2 Health, will moderate this panel that discusses bioelectric medicine. Panelists will be announced at a later date.

Sara Demy, CEO of Demy-Colton, hosts interactive virtual salons featuring industry leaders and distinguished guests exploring today’s most consequential and disruptive topics in healthcare.

Register now